25 results
Thumbnail

D3.385 - A Synthetic Serum Comprising Human IgE Monoclonal Antibodies to Peanut Allergens

Thumbnail

D3.386 - Prevalence and immune mechanisms of rheumatoid arthritis in Kyrgyz highland residents

Thumbnail

D3.387 - Assessment of safety of cryopreserved mesenchymal stem cells in the treatment of atopic dermatitis

Thumbnail

D3.388 - Association of HLA and cytokine production as risk factors for prostate cancer

Thumbnail

D3.389 - The Role Of Metabolic Endotoxemia In The Development Of Systemic Inflammation In Patients With Type 1 And Type 2 Diabetes Mellitus

Thumbnail

D3.390 - Lipopolysaccharide-Binding Protein And sCd14 In Patients With Type 1 Diabetes Mellitus And Diabetic Nephropathy

Thumbnail

D3.391 - The Effect of Bicarbonate Mineral Water on Endotoxemia Markers in Patients with Type 1 Diabetes Mellitus

Thumbnail

D3.392 - Associations Between Markers Of Endotoxin-Binding Systems And Vasoactive Agents In Patients With Rheumatoid Arthritis

Thumbnail

D3.393 - Immunological Profiling of the Kras-Driven Microenvironment in a Murine Model of Endometriosis

Thumbnail

D3.394 - Assessment of safety and tolerability of mesenchymal stem cells and tolerogenic dendritic cells as a therapy for type 1 diabetes

Thumbnail

D3.395 - Analysis of single cell multiome data (transcriptomics + ATAC) from human nasal polyp mast cells

Thumbnail

D3.396 - A new B-cell epitope profiling of glutathione S-transferase allergens supports mite-specific cross-reactivity within different species

Thumbnail

D3.397 - MOG Antibody–Associated Bilateral Optic Neuritis in a Child Following Mycoplasma Infection

Thumbnail

D3.440 - Long-Term Efficacy and Safety of Donidalorsen for Hereditary Angioedema Among Patients in Europe: A Regional Analysis of the OASISplus Study

Thumbnail

D3.441 - Switching to Donidalorsen for Hereditary Angioedema: 1-Year Results From the Phase 3 OASISplus Study

Thumbnail

D3.444 - Efficacy and Safety of Donidalorsen for Patients With Hereditary Angioedema in Europe Who Switched From Prior Long-Term Prophylaxis: Results From the OASISplus Study

Thumbnail

D3.445 - Validation of a Novel Serum-Based Indirect Basophil Activation Test (iBAT) to Evaluate Efficacy of a Pivotal Phase III PQ Grass Immunotherapy Trial

Thumbnail

D3.437 - Impact of benralizumab on fatigue and health-related quality of life in patients with hypereosinophilic syndrome: findings from the NATRON phase 3 trial

Thumbnail

D3.438 - Clinical outcomes with navenibart according to baseline attack rate, body mass index, and age: results of the ALPHA-STAR trial

Thumbnail

D3.439 - Donidalorsen For The Treatment Of Hereditary Angioedema: 1-Year Results From The OASISplus Open-Label Extension Cohort